Anja König is a Managing Director at the Novartis Venture Fund in the Basel office. She is active in Switzerland and Europe and also manages a USD20 million fund in Korea. Dr. König also serves on the board of directors for Nabriva, Heptares, Covagen, Diagnoplex, and Bicycle Therapeutics. Before her appointment to the Novartis Venture Fund she held the position of assistant to the Chairman and CEO of Novartis.

Prior to joining Novartis Dr. König was an Associate Partner at McKinsey and Company in New York City, a global consultancy, where she was a leader in McKinsey’s North American Pharmaceutical Practice and a knowledge expert on pharmaceutical research and drug discovery. Dr. König has experience working in the US, Europe and Emerging Markets. Anja König is a scientist by training and holds a PhD in physics from Cornell University.